Platinum Equity acquired LifeScan from Johnson & Johnson for $2.1bn.

Platinum Equity acquired LifeScan, a world leader in blood glucose monitoring and maker of the OneTouch brand of products, from Johnson & Johnson for $2.1bn. “LifeScan is an innovative company that has been a leader in diabetes care for more than 30 years,” said Platinum Equity Partner Jacob Kotzubei. “We believe strongly in the company’s core mission and are committed to helping LifeScan continue improving the quality of life for people living with diabetes.”